NASDAQ:CTKB
Cytek Biosciences, Inc.
- Stock
Last Close
6.18
17/05 20:00
Market Cap
1.15B
Beta: -
Volume Today
541.75K
Avg: 1.13M
PE Ratio
−73.77
PFCF: −132.08
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
asset turnover | 0.82 - | 0.42 48.70% | 0.28 34.62% | 0.32 14.44% | 0.39 22.82% | |
cash conversion cycle | 312.99 - | 249.32 20.34% | 302.80 21.45% | 359.63 18.77% | 358.71 0.26% | |
cash per share | 0.30 - | 5.24 1,672.82% | 4.75 9.26% | 2.54 46.62% | 1.94 23.42% | |
company equity multiplier | -1.69 - | -13.72 713.42% | 1.14 108.31% | 1.22 7.07% | 1.27 3.66% | |
days of inventory outstanding | 230.35 - | 204.27 11.32% | 240.59 17.78% | 278.71 15.84% | 265.83 4.62% | |
days of payables outstanding | 29.27 - | 26.13 10.73% | 22.69 13.15% | 27.81 22.57% | 13.24 52.39% | |
days of sales outstanding | 111.90 - | 71.18 36.39% | 84.90 19.27% | 108.73 28.07% | 106.13 2.39% | |
dividend yield | 0.00 - | |||||
ebit per revenue | 0.06 - | 0.15 128.56% | 0.05 65.75% | -0.01 122.09% | -0.14 1,126.16% | |
ebt per ebit | -4.37 - | 1.06 124.16% | 0.92 12.67% | -0.69 174.79% | 0.60 186.41% | |
effective tax rate | -0.03 - | -0.35 955.24% | 0.25 173.30% | -0.97 483.92% | 0.23 123.34% | |
enterprise value multiple | 466.72 - | 27.96 94.01% | 115.46 313.04% | 285.64 147.38% | -64.23 122.49% | |
fixed asset turnover | 55.60 - | 43.38 21.98% | 21.87 49.59% | 5.95 72.79% | 6.60 10.86% | |
free cash flow per share | -0.14 - | 0.43 398.80% | 0.00 99.20% | -0.16 4,839.87% | 0.00 102.04% | |
gross profit margin | 0.50 - | 0.56 12.44% | 0.62 11.05% | 0.62 0.48% | 0.57 7.90% | |
interest coverage | 3.73K - | 41.02 98.90% | 3.70 90.97% | -0.71 119.16% | -12.72 1,692.49% | |
inventory turnover | 1.58 - | 1.79 12.77% | 1.52 15.10% | 1.31 13.68% | 1.37 4.85% | |
long term debt to capitalization | 0.03 - | 0.04 32.96% | ||||
net income per ebt | 1.03 - | 1.35 30.26% | 0.74 44.80% | 2.04 175.31% | 0.77 62.17% | |
net profit margin | -0.29 - | 0.21 171.92% | 0.03 83.49% | 0.02 54.51% | -0.06 500.78% | |
operating cash flow per share | -0.13 - | 0.48 456.31% | 0.06 87.44% | -0.09 250.71% | 0.04 142.93% | |
operating cycle | 342.26 - | 275.45 19.52% | 325.49 18.17% | 387.44 19.03% | 371.95 4.00% | |
operating profit margin | 0.06 - | 0.15 128.56% | 0.05 65.75% | -0.01 122.09% | -0.14 1,126.16% | |
payables turnover | 12.47 - | 13.97 12.02% | 16.09 15.15% | 13.12 18.41% | 27.57 110.06% | |
pretax profit margin | -0.28 - | 0.16 155.22% | 0.05 70.09% | 0.01 83.48% | -0.08 1,159.56% | |
price fair value | -45.88 - | -36.94 19.50% | 3.08 108.34% | 3.23 4.80% | 3.14 2.80% | |
receivables turnover | 3.26 - | 5.13 57.22% | 4.30 16.16% | 3.36 21.92% | 3.44 2.45% | |
return on assets | -0.24 - | 0.09 136.90% | 0.01 89.20% | 0.00 47.94% | -0.02 592.25% | |
return on capital employed | 0.08 - | 0.07 6.53% | 0.01 78.84% | -0.00 125.98% | -0.06 1,437.53% | |
return on equity | 0.40 - | -1.21 400.13% | 0.01 100.90% | 0.01 44.26% | -0.03 610.25% | |
total debt to capitalization | -0.21 - | -0.21 0.02% | 0.04 117.29% | 0.04 12.84% | 0.06 39.32% |
All numbers in USD (except ratios and percentages)